Adma Biologics Inc

NASDAQ:ADMA   3:59:58 PM EDT
1.95
+0.02 (+1.04%)
Products

ADMA Biologics Announces FDA Approval Of Extended Shelf Life For Asceniv & Bivigam From 24 To 36 Months

Published: 03/25/2022 11:14 GMT
Adma Biologics Inc (ADMA) - Adma Biologics Announces FDA Approval of Extended Shelf Life for Asceniv™ & Bivigam® From 24 to 36 Months.
Adma Biologics Inc - Extended Shelf Life Asceniv & Bivigam Now Commercially Available to U.S. Healthcare Providers.